Last C$0.19 CAD
Change Today 0.00 / 0.00%
Volume 70.0K
VRS On Other Exchanges
As of 3:53 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

verisante technology inc (VRS) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/22/13 - C$0.52
52 Week Low
11/21/13 - C$0.17
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

verisante technology inc (VRS) Related Businessweek News

No Related Businessweek News Found

verisante technology inc (VRS) Details

Verisante Technology, Inc., a medical device company, engages in the development and commercialization of skin cancer detection systems. The company’s products include Verisante Aura, a spectroscopy system to aid in the detection of various skin cancers, including basal cell carcinoma, squamous cell carcinoma, melanoma, pre-cancerous lesions, and actinic keratosis; and Verisante Core for the detection of other types of cancer, including lung, gastro-intestinal, colorectal, and cervical cancers. It has a licensing agreement with the BC Cancer Agency to commercialize a skin cancer detector based on Raman Spectroscopy. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology, Inc. in January 2011. Verisante Technology, Inc. was founded in 2006 and is headquartered in Vancouver, Canada.

18 Employees
Last Reported Date: 11/28/13
Founded in 2006

verisante technology inc (VRS) Top Compensated Officers

Chief Executive Officer, President, Director,...
Total Annual Compensation: C$312.5K
Chief Financial Officer, Corporate Counsel an...
Total Annual Compensation: C$165.3K
Compensation as of Fiscal Year 2012.

verisante technology inc (VRS) Key Developments

Verisante Technology, Inc. Hires Jason Mangler as Director of Sales

Verisante Technology, Inc. announced that the company has hired Jason Mangler as Director of Sales to guide the sales and marketing strategy. Verisante has also hired Kim Ellis, as the Company's Sales Representative for Western Canada.

Verisante Technology, Inc. to Introduce VRS(TM) Verisante Research System

Verisante Technology, Inc. announced that it is launching a new product at the SPIE Photonics West 2014 industry exhibit in San Francisco, California from February 4, 2014 - February 6, 2014. The company will be introducing and demonstrating the VRS(TM) Verisante Research System, a revolutionary rapid Raman spectroscopy system designed for the scientific research community.

Verisante Technology, Inc., Annual General Meeting, Feb 28, 2014

Verisante Technology, Inc., Annual General Meeting, Feb 28, 2014., at 14:00 Pacific Standard Time. Location: 306-2309 west 41 avenue. Agenda: To receive and consider the information circular, the financial statements and the report of the company's auditor; to consider the elect directors; to appoint auditors for the company and authorize the directors to fix their remuneration; to consider the approve an ordinary resolution adopting the company's 2014 stock option plan; to consider transact such further business as may be properly brought before the meeting or any adjournment thereof.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRS:CN C$0.19 CAD 0.00

VRS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lucid Inc $0.53 USD 0.00
Mauna Kea Technologies €11.00 EUR -0.15
Medx Health Corp C$0.11 CAD 0.00
MELA Sciences Inc $0.54 USD +0.0152
Optiscan Imaging Ltd A$0.05 AUD -0.003
View Industry Companies

Industry Analysis


Industry Average

Valuation VRS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 14.8x
Price/Book 2.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 16.2x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERISANTE TECHNOLOGY INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at